Skip to content
Evercore
Toggle search
Toggle navigation
Explore
Home
Who We Are
Overview
Core Values
Leadership
Board
Our Businesses & Capabilities
Investment Banking
Strategic Advisory
Liability Management & Restructuring
Capital Markets Advisory
Private Capital Advisory & Fundraising
Equities
Research
Sales & Trading
Corporate Access & Conferences
Wealth Management
Our Transactions
Our Team
Investment Banking
Equities
Wealth Management
Corporate Group Leadership
Alumni Network
Our Impact
Diversity, Equity and Inclusion
Our Commitment
Focus Areas
Global Diversity Council
Community
Sustainability
Evercore Foundation
Careers
The Evercore Difference
Students & Graduates
Professionals
Benefits
Media
Investor Relations
Overview
Corporate Governance
Board of Directors
Governance Documents
Financials & Filings
SEC Filings
Quarterly Results
Annual Reports
Sustainability
News Releases & Events
News
Events & Presentations
Resources
Online Investor Kit
Information Request
Analyst Coverage
Stock Information
Join Our Team
Students & Graduates
Professionals
Contact Us
Back
September 5, 2023
Advised Ascendis on its synthetic royalty funding agreement with Royalty Pharma
Return to News